Delivery Order SPE2DB22D3301-SPE2DB25FZ0RB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $1,782.75, represents a non-competitive, non-set-aside award with an ultimate completion date of July 25, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $47,260.15 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Naltrexone 50 mg tablets in 90-count packages, with a ceiling value of $7,106.19 and a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,362.28, is for the delivery of Naltrexone 50 mg tablets in 60-count packaging. It is a firm fixed-price delivery order with a performance period ending on May 6, 2025. The contract is not set aside and was awarded on May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,370.20 firm fixed-price delivery order is for the supply of 60-count Naltrexone 50 mg tablets. The contract has an ultimate completion date of September 11, 2024 and is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $1,434 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50mg naltrexone tablets. Under this single award, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 3rd to fulfill the agency's requirement. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naltrexone 50 mg tablets. The order, valued at $2,078.94, is a firm fixed-price contract with a completion date of September 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp in the amount of $4,768.43. The order is for 4565427144 - Naltrexone 50 MG Tablet 60s, which are pharmaceutical products used to treat opioid dependence. The delivery order falls under the DLA's Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999, that provides a range of medical commodities to support military treatment programs and facilities...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Naltrexone 50 mg tablets over a 2-year period ending in June 2024. The contract is a Delivery Order with a Firm Fixed Price of $1,356.78 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0RBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units, with a ceiling value of $12,745.23. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's substantial IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. Naltrexone, an opioid antagonist medication, represents a component of the broader pharmaceutical supply portfolio the company delivers under its federal contract framework to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 9/8/25 |